Cordyceps sinensis Increases the Expression of Major Histocompatibility Complex Class II Antigens on Human Hepatoma Cell Line HA22T/VGH Cells

American Journal of Chinese Medicine

Volumn 26, Issue 2, 1998, Pages 159-170

  Chiu, Jen Hwey ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HERBACEOUS AGENT; HLA ANTIGEN CLASS 2; PLANT EXTRACT;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; HUMAN; LIVER CELL CARCINOMA;

CARCINOMA, HEPATOCELLULAR; DRUGS, CHINESE HERBAL; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; PLANT EXTRACTS; TUMOR CELLS, CULTURED;

EID: 0032239303     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X9800021X     Document Type: Article

References (27)

1. Anderson, G., E.J. Jenkinson, N.C. Moore, and J.T. Owen. MHC class Il-positive epithelium and mesenchyme cells are both required for T-cell development in the thymus. Nature, 362: 70-72, 1993.
2. Bodmer, W.F, M.J. Browning, P Krausa, A. Rowan, D.C. Bickness, and Bodmer. Tumor escape from immune response by variation in HLA expression and other mechanisms. Ann. N Y. Acad Sei. 90:42-49,1993.
3. Chang, C, Y. Lin, T.W. O. Lee, C.K Chou, T.S. Lee, T.J. Liu, F.K. Peng, T.Y. Chen, and C. Hu. Induction of plasma protein secretion in a newly established human hepatoma cell line. Mol Cell Biol. 3:1133-1137, 1983.
4. Chen, Y.J., M.S. Shiao, S.S. Lee and S.Y. Wang. Effect ofCordyceps sinensis on the proliferation and differentiation of human leukemic U937 cells. Life Sei. 60: 2349-2359, 1997.
5. Chiu, J H., H.M. Chang, H.L. Koa, L.H. Wu, and W.Y. Lui. Establishment and characterization of two cell lines derived from a single hepatocellular carcinoma containing multiploid DNA distribution. Cancer Detect. Prevent. 20: 43-51, 1996.
6. Corzo, D., M. Salazar, C.B. Granja, and E.J. Yunis. Advances in HLA genetics. Exp. Clin. Immunogenet 12; 156- 170, 1995.
7. Doukas, J., and J.S. Pober. Lymphocyte-mediated activation of cultured endothelial cells (EC) CD4+ T cells inhibit EC class II MHC expression despite secreting IFN-gamma and increasing EC class IMHC and intercellular adhesion molecule-1 expression. J. Immunol. 145:1088-1098, 1990.
8. Editorials. HLA and disease association: the case of gastric cancer. Gastroenterology, 3: 523526,1996.
9. Franco, A., V. Barnaba, P Natali, C Balsaro, A. Musca, and F. Balsano. Expression of class I and class II major histocompatibility antigens on human hepatocytes. Hepatology, 8:449-454,1988.
10. Health Statistics. National Health Administration, Taiwan Provincial Health Department and Taipei City Health Department, Republic of China. 1992, vol. 11:90-91.
11. Hu, C.P, S H. Han, W Y Lui, H.C Hsu, M.Y. Lin, P.H. Lin, and L.R. Chen. Monoclonal antibodies against antigens expressed on human hepatocellular carcinoma cells. Hepatology, 6: 1396-1402,1986.
12. Klimecki, W.T., B.W. Futscher, T.M. Grogan, and W.S. Dalton. P-glycoprotein expression and function in circulating blood cells from normal volunteers. Blood, 83: 2451-2458, 1994.
13. Krief, P., Y. Augery-Bourget, S. Plaisance, M.F. Merck, E. Assier, V. Tanchou, M. Billard, C. Bouclleix, C. Jasmin, and B. Azzarone. A new cytokine (IK) down-regulating HLA class II: monoclonal antibodies, cloning and chromosome localization. Oncogene, 9: 3449-3456 ,1994.
14. Kuo, Y.C., W.J. Tsai, M.S. Shiao, C.F. Chen and C.Y. Lin. Cordyceps sinensis as an immunomodulatory agent. Am. J. Chin. Med. 24: 111-125,1996.
15. Kurokohchi, K., M. Carrington, D L. Mann, T.B. Simonis, M.A.Alexander-Miller, S.M. Feinstone, T. Akatsuka, and J.A. Berzofsky. Expression of HLA class I molecules and the transporter associated with antigen processing in hepatocellular carcinoma. Hepatology, 23: 1181-1188,1996.
16. Lobo-Yeo A., G. Senaldi, B. Portmag A.PMowat, G. Mieli-Vergani, andD. Vergani. Class I and class II major histocompatibility complex antigen expression on hepatocytes: a study in children with liver disease. Hepatology, 12: 224-232,1990.
17. McDougall, C.J., S.S. Nogi, I.S. Goldman, T Godwin, J. Felix, J. Decosse, and B. Rigas. Reduced expression of HLA class I and II antigens in colon cancer. Cancer Res. 50: 8023-8027, 1990.
18. Ohmori, T., K. Tamura, S. Tsura, and I.C. Nomoto. Antitumor activity of protein-bound polysaccharide from Cordyceps ophioglossides in mice. Jpn. J. Cancer Res. 77: 1256-1263, 1986.
19. Oka, H., S. Yamamoto, T. Kuroki, S. Harihara, T. Marumo, S.R. Kim, T Monna, K. Kobayashi, andT. Tango. Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saikoto (TJ-9). Cancer, 76: 743-749,1995.
20. Shen, Y.C, and C.Y. Hong. Effect of trilinolein on cyclic nucleotide formation in human platelets: relationship with its antiplatelet effect and nitric oxide synthesis. Br. J. Pharmacol. 116: 1644-1648,1995.
21. Shiao, M.S., L.J. Lin, C. Y Lien, S.S. Tzean, and K.R. Lee. Natural products in Cordyceps, Proc. Natl. Sei. Counc. R.O.C. 13: 382-387. 1989.
22. Shiao, M.S., Z.N. Wang, L.J. Lin, J.Y. Lien, and J.J. Wang. Profiles of nucleosides and nitrogen bases in Chinese medicinal fungus Cordyceps sinensis and related species. Bot. Bull, Acad. Sci. 35: 261-267,1994.
23. So, S.K.S., J.L. Platt, N.L. Ascher, and D.C Snover. Increased expression of class I major histocompatibility complex antigens on hepatocytes in rejecting human liver allografts. Transplantation, 43:79-85,1987.
24. Sung, C.H., C.P. Hu, H.C. Hsu, A.K. Ng, C.K. Chou, L.P. Ting and T.S. Su. Expression of class I and class II major histocompatibility antigens on human hepatocellular carcinoma. J. Clin. Invest. 83 :421-429, 1989.
25. Vidovic, D., F. Falcioni, D.R. Bolin, and Z.A. Nagy. Down-regulation of class II major histocompatibility complex molecules on antigen presenting cells after interaction with helper T cells. Eur. J. Immunol. 25:1326-1331, 1995.
26. Wadee, A.A., A. Paterson, K.A. Coplan, and S.G. Reddy. HLA expression in hepatocellular carcinoma cell lines. Clin Exp. Immunol. 97: 328-333,1994.
27. Wang S.Y., M.L. Hsu, H.C. Hsu, C H. Tzeng, S.S. Lee, and M.S. Shiao. The antitumor effects of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int. J. Cancer, 70: 699-705, 1997.